Arkolith/Insider Trading/ALLO/Form 4

Messemer Deborah M.

DirectorAllogene Therapeutics, Inc. (ALLO) · full profile →Form 4 · filed Jun 20, 2024
Net Selling
Open-Market Buys
$0
Open-Market Sells
$43K
Net Open-Market Flow
-$43K
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jun 18, 2024Sell(S)19K$2.28$43K167K

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001593968-24-000878) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML